Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. RAPP
RAPP logo

RAPP News & Events

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

RAPP News

Form 144: Rapport Therapeutics (RAPP.US) 10% Stakeholder Plans to Sell $17.18 Million in Common Shares

3d agomoomoo

Rapport Therapeutics Reports Q4 Earnings Miss

Mar 10 2026seekingalpha

Xenon Pharmaceuticals Reports Positive Phase 3 X-TOLE2 Study Results

Mar 09 2026Benzinga

RAPPORT THERAPEUTICS STOCK RISES 5% AFTER AWARDING CHINA RIGHTS FOR EPILEPSY MEDICATION

Mar 09 2026moomoo

Rapport Partners with Tenacia for RAP-219 Development in Greater China

Mar 09 2026Yahoo Finance

Rapport Therapeutics (RAPP) Receives FDA Clearance to Advance RAP-219 into Phase 3 Trials

Jan 08 2026NASDAQ.COM

Cormorant Increases Stake in Rapport Therapeutics by 251,600 Shares Worth $94.82 Million

Dec 22 2025Fool

Cormorant Increases Stake in Rapport Therapeutics by 251,600 Shares Worth $61.38 Million

Dec 22 2025NASDAQ.COM

RAPP Events

04/09 18:50
Trump Proposes Direct Talks Between Israel and Lebanon, Market Sentiment Improves
Reports that President Trump may be advocating for direct talks between Lebanon and Israeli negotiators to help preserve the Iranian ceasefire reversed the initial cautious sentiment in the markets on Thursday and helped the S&P 500 to notch its seventh consecutive gain.  Consumer Cyclicals and Industrials sectors were the top performers on the session as Energy lagged once again, with WTI Crude Oil pricing heading back below $100 per barrel after briefly rising toward $103.  The benchmark is now just over a percentage point away from the levels seen just prior to the strikes on Tehran in late February.  Likewise, the Vix volatility gauge has moved back below the key 20-level, though the rally in Treasuries has stalled in the wake of this morning's PCE inflation report and ahead of Friday's CPI data.In addition to macro data developments, investors are hopeful that the geopolitical uncertainty will continue to clear as talks between Iranian and U.S. negotiators begin on Friday.  Headlines from Thursday evening, however, suggest that there still may be some cause for concern - in a post on Truth Social, President Trump remarked that Iran is doing a "very poor job" on allowing oil through Hormuz.  In the opening hour, S&P e-minis are down by a decimal below $68.60, with WTI prices also bouncing back toward the $100 mark.Check out this evening's top movers from around Wall Street, compiled by The Fly.HIGHER AFTER EARNINGS -Simulations Plusup 12.5%ALSO HIGHER -Cars.comup 2.2% after cutting headcount by 11%, affirming guidanceRapport Therapeuticsup 2.0% after being started at Strong Buy at Raymond JamesDOWN AFTER EARNINGS -Beam Globaldown 11.1%FGI Industries (down 9.2%WD-40 Companydown 0.5%

RAPP Monitor News

No data

No data

RAPP Earnings Analysis

No Data

No Data

People Also Watch